Of course it will mate, think that the dilution issue has become a non-issue for most investors now, it is absolutely needed going forward to fund the R&D. Ideally coming to the pointy end a sp way North of $14 would have been far better.
Will be interesting to learn if any amount of dilution makes for a optimum outcome.
Long, long way from that ‘No more CRs’ comment though.
Ann: Plan to Pursue Re-domiciliation, Nasdaq listing and US IPO, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.70 |
Change
0.200(3.64%) |
Mkt cap ! $87.92M | |||
| Open | High | Low | Value | Volume |
| $5.29 | $5.70 | $5.29 | $143.8K | 25.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3220 | $5.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.72 | 170 | 1 |
View Market Depth
| Last trade - 15.01pm 07/08/2025 (20 minute delay) ? |
| AVR (ASX) Chart |